Dyadic International, Inc. (Nasdaq: DYAI) , d/b/a Dyadic Applied BioSolutions (“Dyadic” or the “Company”), a biotechnology company focused on the development and commercialization of scalable ...

Mass production of recombinant proteins using yeast cell "factories" needs methanol, a compound that requires safe handling, carries the risk of catching fire, and sometimes produces harmful ...

Recombinant proteins are crucial in pharmaceutical and other industries. A production method uses plants as hosts in transient protein expression systems. Researchers at the University of Tsukuba ...

Antibodies are the number one immune cells that fight against infection and diseases. However, beyond their natural usage, biochemistry has devised several ways in which these antibodies can be ...

Financing follows a series of major milestones for Neion Bio, including the company’s emergence from stealth, execution of ...

Recombinant antibody production has emerged as a potent and ground-breaking technology in biomedical research. It has completely transformed the way scientists and researchers study illnesses, create ...

Stay up to date on the latest science with Brush Up Summaries. “Molecular farming started out with transgenic plants,” said Rybicki. Scientists developed several strategies to produce transgenic ...

The interview comes as Kraig Labs continues to execute on its strategy to scale commercial production of recombinant spider silk through its proprietary, genetically engineered silkworm platform, an ...

The safety and quality control of parenteral pharmaceuticals, biologics, and medical devices depend heavily on the Bacterial Endotoxin Test (BET). Historically, Limulus Amebocyte Lysate (LAL), derived ...